Publication

Yang Y, et al. SGLT2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: Meta-Analysis of RCTs. JAMA, 2026

PMID 42925557

Метаанализ 85 РКИ, 70 543 участника с ССЗ, диабетом, СН или ХБП. Гемоглобин +0,60 г/дл (95% ДИ 0,55–0,66), гематокрит +2,36 п.п. Клиническое значение неясно.

News about this publication

Scales

Identifiers

PMID
42925557
DOI
10.1001/jama.2026.19921

Original sources

Details

Journal
JAMA
Year
2026

A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.